Burden of disease in treated rheumatoid arthritis patients: Going beyond the joint

被引:114
作者
Cutolo, Maurizio [1 ,2 ]
Kitas, George D. [3 ,4 ]
van Riel, Piet L. C. M. [5 ]
机构
[1] Univ Genoa, Dept Internal Med, Res Labs, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Internal Med, Acad Div Clin Rheumatol, I-16132 Genoa, Italy
[3] Dudley Grp NHS Fdn Trust, Dept Rheumatol, Dudley, England
[4] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England
[5] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 ED Nijmegen, Netherlands
关键词
NECROSIS-FACTOR-ALPHA; QUALITY-OF-LIFE; ANTI-TNF THERAPY; C-REACTIVE PROTEIN; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; NONSPECIFIC INTERSTITIAL PNEUMONIA; MODIFYING ANTIRHEUMATIC DRUGS; ADALIMUMAB PLUS METHOTREXATE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION;
D O I
10.1016/j.semarthrit.2013.08.004
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective: The disease burden in rheumatoid arthritis (RA) extends beyond the joint. This article evaluates the physical and psychosocial extra-articular burden of treated RA and relationships among diverse disease manifestations. Methods: MEDLINE searches identified papers published in English from January 2003 to December 2012 that evaluated systemic complications and psychosocial aspects associated with RA. Preference was given to studies with randomized cohorts and large ( > 100) sample sizes. Of 378 articles identified in the initial search, 118 were selected for inclusion. Results: RA is associated with multiple comorbidities and psychosocial impairments, including cardiovascular disease, osteoporosis, interstitial lung disease, infection, malignancies, fatigue, depression, cognitive dysfunction, reduced work performance, work disability, and decreased health-related quality of life. The etiology of the extra-articular burden may reflect the systemic inflammation and immune system alteration associated with RA, metabolic imbalances and side effects related to treatment, or the influence of comorbidities. Strategies that may help to reduce the extra-articular disease burden include personalized medicine and the potential introduction of treatments with new mechanisms of action. Conclusion: Despite improvements in treating joint disease, the extra-articular burden in RA remains substantial, encompassing multiple comorbidities and psychosocial impairments. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:479 / 488
页数:10
相关论文
共 150 条
[1]
Subclinical Atherosclerosis and Endothelial Dysfunction in Patients with Early Rheumatoid Arthritis as Evidenced by Measurement of Carotid Intima-Media Thickness and Flow-Mediated Vasodilatation: An Observational Study [J].
Adhikari, Maitrayee Chatterjee ;
Guin, Aharna ;
Chakraborty, Sumit ;
Sinhamahapatra, Pradyot ;
Ghosh, Alakendu .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2012, 41 (05) :669-675
[2]
Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis [J].
Ahmed, Hamada M. M. Sayed ;
Youssef, Mahmoud ;
Mosaad, Youssef M. .
CLINICAL RHEUMATOLOGY, 2010, 29 (11) :1237-1243
[3]
Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis [J].
Al-Aly, Ziyad ;
Pan, Hui ;
Zeringue, Angelique ;
Xian, Hong ;
Mcdonald, Jay R. ;
El-Achkar, Tarek M. ;
Eisen, Seth .
TRANSLATIONAL RESEARCH, 2011, 157 (01) :10-18
[4]
Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis [J].
Amari, Wassila ;
Zeringue, Angelique L. ;
McDonald, Jay R. ;
Caplan, Liron ;
Eisen, Seth A. ;
Ranganathan, Prabha .
RHEUMATOLOGY, 2011, 50 (08) :1431-1439
[5]
Ang DC, 2005, J RHEUMATOL, V32, P1013
[6]
Cognitive impairment in rheumatoid arthritis [J].
Appenzeller, S ;
Bértolo, MB ;
Costallat, LTL .
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2004, 26 (05) :339-343
[7]
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register [J].
Askling, J. ;
Baecklund, E. ;
Granath, F. ;
Geborek, P. ;
Fored, M. ;
Backlin, C. ;
Bertilsson, L. ;
Coster, L. ;
Jacobsson, L. T. ;
Lindblad, S. ;
Lysholm, J. ;
Rantapaa-Dahlqvist, S. ;
Saxne, T. ;
van Vollenhoven, R. ;
Klareskog, L. ;
Feltelius, N. .
ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) :648-653
[8]
Morphological and quantitative assessment of mast cells in rheumatoid arthritis associated non-specific interstitial pneumonia and usual interstitial pneumonia [J].
Atkins, SR ;
Matteson, EL ;
Myers, JL ;
Ryu, JH ;
Bongartz, T .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (05) :677-680
[9]
Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia [J].
Atkins, SR ;
Turesson, C ;
Myers, JL ;
Tazelaar, HD ;
Ryu, JH ;
Matteson, EL ;
Bongartz, T .
ARTHRITIS AND RHEUMATISM, 2006, 54 (02) :635-641
[10]
Systematic Review and Meta-Analysis: Anti-Tumor Necrosis Factor α Therapy and Cardiovascular Events in Rheumatoid Arthritis [J].
Barnabe, Cheryl ;
Martin, Billie-Jean ;
Ghali, William A. .
ARTHRITIS CARE & RESEARCH, 2011, 63 (04) :522-529